BG26387A3 - Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они - Google Patents

Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они

Info

Publication number
BG26387A3
BG26387A3 BG028125A BG2812574A BG26387A3 BG 26387 A3 BG26387 A3 BG 26387A3 BG 028125 A BG028125 A BG 028125A BG 2812574 A BG2812574 A BG 2812574A BG 26387 A3 BG26387 A3 BG 26387A3
Authority
BG
Bulgaria
Prior art keywords
hexachydro
dibenzo
pyran
obtaining
obtaining hexachydro
Prior art date
Application number
BG028125A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Archer
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG26387A3 publication Critical patent/BG26387A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BG028125A 1973-11-05 1974-11-05 Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они BG26387A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (1)

Publication Number Publication Date
BG26387A3 true BG26387A3 (bg) 1979-03-15

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
BG028125A BG26387A3 (bg) 1973-11-05 1974-11-05 Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они

Country Status (26)

Country Link
US (1) US3968125A (2)
JP (1) JPS6033835B2 (2)
AR (1) AR202318A1 (2)
AT (1) AT336012B (2)
BE (1) BE821716A (2)
BG (1) BG26387A3 (2)
CA (1) CA1023753A (2)
CH (1) CH605894A5 (2)
CS (1) CS193507B2 (2)
DD (1) DD116230A5 (2)
DE (1) DE2451934C2 (2)
DK (1) DK136719B (2)
ES (1) ES431674A1 (2)
FR (1) FR2249664B1 (2)
GB (1) GB1487637A (2)
HU (1) HU169193B (2)
IE (1) IE40023B1 (2)
IL (1) IL45644A (2)
NL (1) NL7414439A (2)
PH (1) PH11788A (2)
PL (2) PL93908B1 (2)
RO (1) RO71766A (2)
SE (1) SE415762B (2)
SU (1) SU524517A3 (2)
YU (1) YU36515B (2)
ZA (1) ZA745751B (2)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (2) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
PT1477186E (pt) * 2002-02-19 2010-02-11 Shionogi & Co Antipruriginosos
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
JP5704925B2 (ja) 2008-02-08 2015-04-22 ウェルズ ファーゴ バンク ナショナル アソシエイション オリゴマー−カンナビノイドコンジュゲート
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2019016814A1 (en) 2017-07-20 2019-01-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. PHARMACEUTICAL FILM COMPOSITIONS FOR THE ADMINISTRATION OF LIPOPHILIC COMPOUNDS IN AND / OR THROUGH THE SKIN
WO2019049145A1 (en) 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. COMPOSITIONS AND METHODS FOR NASAL BRAIN MEDICATION ADMINISTRATION FOR SYSTEMIC EFFECT
CA3116187A1 (en) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
US20220008354A1 (en) 2018-11-04 2022-01-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
DE2451934C2 (de) 1983-10-06
YU265874A (en) 1982-02-25
CA1023753A (en) 1978-01-03
FR2249664A1 (2) 1975-05-30
PL95748B1 (pl) 1977-11-30
PL93908B1 (2) 1977-07-30
HU169193B (2) 1976-10-28
AR202318A1 (es) 1975-05-30
ES431674A1 (es) 1976-11-16
AU7321274A (en) 1976-03-18
SE415762B (sv) 1980-10-27
JPS5071678A (2) 1975-06-13
DK136719C (2) 1978-04-24
US3968125A (en) 1976-07-06
DK136719B (da) 1977-11-14
CH605894A5 (2) 1978-10-13
ATA886374A (de) 1976-08-15
YU36515B (en) 1984-02-29
JPS6033835B2 (ja) 1985-08-05
SE7413833L (2) 1975-05-06
IE40023L (en) 1975-05-05
DD116230A5 (2) 1975-11-12
RO71766A (ro) 1982-12-06
CS193507B2 (en) 1979-10-31
ZA745751B (en) 1976-04-28
DE2451934A1 (de) 1975-05-07
BE821716A (fr) 1975-04-30
NL7414439A (nl) 1975-05-07
SU524517A3 (ru) 1976-08-05
IL45644A0 (en) 1974-11-29
DK573274A (2) 1975-07-07
IL45644A (en) 1978-03-10
IE40023B1 (en) 1979-02-28
GB1487637A (en) 1977-10-05
PH11788A (en) 1978-07-05
AT336012B (de) 1977-04-12
FR2249664B1 (2) 1978-03-24

Similar Documents

Publication Publication Date Title
BG26387A3 (bg) Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они
BG25069A3 (bg) Метод за получаване на заместени естери
BG21385A3 (bg) Метод за получаване на циклохексанови съединения
RO65649A (ro) Procedeu pentru obtinerea de pirimidine
RO68025A (ro) Procedeu pentru obtinerea 3-metilmercaptopropionaldehidei
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
BG25804A3 (bg) Метод за получаване на псевдотризахариди
BG21856A3 (bg) Метод за получаване на пиримидин-тионотиолфосфоно-кисели естери
BG22820A3 (bg) Метод за получаване на пиразолони-5
SE405700B (sv) Forfarande for forvermning av former
BG25997A3 (bg) Метод за получаване на 7- ациламидо- 7- метоксицефалоспорини
BG24408A3 (bg) Метод за получаване на бис-2-метил-3-хидрокси-4-хидрокси-метил- придил-5-метил-тиокарбонат
SE383359B (sv) Stotvagsforma for schaktugn
BG22404A3 (bg) Метод за получаване на а-аминоацил-3-халоцефалоспорини
BG27747A3 (bg) Метод за получаване на субституирани епоксиетани
BG22381A3 (bg) Метод за получаване на диаминобензофенони
BG25794A3 (bg) Метод за получаване на три ацетон амин
BG21849A3 (bg) Метод за получаване на заместени нитробензофенонови производни
BG24406A3 (bg) Метод за получаване на 1-ацилоксифенил-1-хидрокси-2-n- алкиламино-етани
BG27092A3 (bg) Метод за получаване на n-фосфонометилглицинови триестери
BG21852A3 (bg) Метод за получаване на бензиламини
SU455915A1 (ru) Способ получени пирониобата свинца
BG22823A3 (bg) Метод за получаване на нитромидазолови съединения
SU466188A1 (ru) Способ получени станнана
BG24229A3 (bg) Метод за получаване на n-субституирани циклозерини